PT - JOURNAL ARTICLE AU - Masamichi Uehara AU - Tomohiro Ishimaru AU - Hajime Ando AU - Seiichiro Tateishi AU - Hisashi Eguchi AU - Mayumi Tsuji AU - Koji Mori AU - Shinya Matsuda AU - Yoshihisa Fujino AU - for the CORoNaWork Project TI - Worries about COVID-19 infection and psychological distress at work and while commuting AID - 10.1101/2021.02.16.21250657 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.16.21250657 4099 - http://medrxiv.org/content/early/2021/10/01/2021.02.16.21250657.short 4100 - http://medrxiv.org/content/early/2021/10/01/2021.02.16.21250657.full AB - Objective This study examined the relationship between worry about COVID-19 infection in the workplace and while commuting to work and psychological distress in Japan.Methods An internet monitor study was conducted. Out of a total of 33,302 participants, 26,841 people were included. The subjects were asked single-item questions about whether they were worried about COVID-19 infection in general, at work and while commuting to work. Kessler 6 (K6) was used to assess psychological distress.Results The OR was significantly higher in association with worry about infection in the workplace at 1.71 (95%CI 1.53–1.92) and worry about infection while commuting at 1.49 (95%CI 1.32–1.67).Conclusions This study suggests the need for psychological intervention to reduce worry about infection in response to public mental health challenges associated with the COVID-19 pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by a research grant from the University of Occupational and Environmental Health, Japan; a general incorporated foundation (Anshin Zaidan) for the development of educational materials on mental health measures for managers at small-sized enterprises; Health, Labour and Welfare Sciences Research Grants: Comprehensive Research for Women's Healthcare (H30-josei-ippan-002) and Research for the establishment of an occupational health system in times of disaster (H30-roudou-ippan-007); and scholarship donations from Chugai Pharmaceutical Co., Ltd.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of the University of Occupational and Environmental Health, Japan(reference No. R2-079).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData not available due to ethical restrictions.